Association between Wegener's granulomatosis and severe lumbar pain.
Heinz Klinger was the first to describe Wegener's granulomatosis in 1931 during a study conducted at the University of Berlin. About 5 years later, Friedrich Wegener, a German pathologist, described a similar clinical presentation in three patients. After observing these similar clinical presentations in seven other patients years later, he established its diagnosis criteria (21). Thus, Wegener's granulomatosis is a rare systemic autoimmune disease characterized by necrotizing granulomatous vasculitis that primarily affects the small vessels. Generally it affects the upper and lower airways, lungs, and kidneys. Less often, it can affect muscles, joints, skin, eyes, cardiovascular and nervous system (13,2,10,3).
The involvement of the central and peripheral nervous systems are not uncommon, being in approximately 22-50% of patients (13). Peripheral neuropathy (especially mononeuritis multiplex) can be present at 10.6 - 21.2% of patients and less than 10% with involvement of the central nervous system (13,3). Lumbar pain consists in a rare feature of neurological involvement of the patient, which can happen by central or peripheral nervous system.
Although its etiology is still unknown, there are hypothesis that its pathogenesis involves components of cellular and humoral response. The T-cell mediated immunity is responsible for the production and release of pro-inflammatory cytokines including Tumor necrosis factor [alpha] (TNF-[alpha]) and interferon [gamma] that stimulate the expression of surface antigens in activated neutrophils. Among these antigens are proteinase 3 (PR3) and myeloperoxidase which are markers for c-ANCA (cytoplasmic) and p-ANCA (perinuclear- Neutrophil Cytoplasmic Antibody) respectively. The interaction of ANCA with their antigens result in degranulation of neutrophils and formation of toxic products, increasing the inflammatory reaction and leading to tissue damage (2,10).
Neurological manifestations and lumbar pain
Neurological manifestations may be present in 22-50% of patients during the course of the disease (13). The literature mentions three mechanisms by which the nervous system may be affected, proposed by Drachman: 1) necrotizing vasculitis involving brain, spinal and radicular vessels; 2) contiguity extravascular granulomas in the paranasal sinuses, nasal cavities or orbits; 3) primary necrotizing granulomas in the skull, meninges, cranial nerves or brain (3,11,5).
Peripheral nerves are more commonly affected by multiple mononeuritis and sensorimotor distal symmetric polyneuropathy. The main symptoms include pain, numbness and muscle weakness in the affected sites (2,3). Lumbar pain can also occur due to lumbar nerve root compression, an infrequent event. The formation of granulomatous mass along with necrotizing vasculitis which is a characteristic of the disease, lead to compression and consequent ischemia of the nerve root, causing pain as well as sensory and motor deficit in the area innervated by the affected root. Therefore, in the lumbar level injuries, pain may also affect the lower limbs in accordance with the nerve pathway involved. In these cases, as a diagnostic aid can be made a biopsy of nerve root would prove the presence of necrotizing granulomatous vasculitis.
The involvement of the central nervous system mainly includes cerebral ischemic events, involvement of cranial nerves, subdural hematoma, subarachnoid hemorrhage, and more rarely spinal cord compression by involvement of the dura mater, another possible cause of low back pain. Upon reaching the dura mater, vasculitis and granulomatous inflammation typical of GW promotes the formation of a tissue mass and a thickening of the dura that surrounds and compresses the spinal cord, may also affect its nerves and cause symptoms such as weakness, numbness and pain (5,1,20). To assist in diagnosis, in addition to clinical manifestations, imaging tests such as MRI are of paramount importance to identify the granulomatous mass, dural thickening as well as its extent and affected sites. As a result of this granulomatous inflammation, diseases such as herniated discs, lumbosacral plexopathy, lumbosacral radiculopathy, osteitis and synovitis can affect lumbar area, causing severe pain in this region.
For diagnosing should be used clinical patient data, imaging tests such as chest radiography, MRI or CT scan, biopsy of the lesion and also the presence of anti-neutrophil cytoplasmic antibody (ANCA)--serum marker of Wegener's granulomatosis--demonstrated by indirect immunofluorescence or ELISA (Enzyme-Linked Immunosorbent Assay). The c-ANCA pattern is more related to GW, with a specificity of 90%, but its negativity is insufficient to rule out the diagnosis. The title of ANCA must be accompanied as it can be directly related to disease activity (13,14,18).
The American Academy of Rheumatology recommends the use of the diagnostic criteria published in 1990: nasal or oral inflammation; nodules, fixed infiltrates or cavitation on chest radiography; microscopic hematuria or more than five erythrocytes per high-power field; granulomatous inflammation on biopsy. Having at least two of these criteria may mean a diagnosis of GW with 82.2% sensitivity and 92% specificity compared to other vasculitis (2,15,16).
The presence of severe back pain associated to the items listed in Table 1 or in patients previously implanted with GW may represent neurological involvement in the disease course. Thus, these signals are extremely important to differential diagnosis of low back pain due to other causes.
A biopsy of the lesion may be performed to confirm the diagnosis and exclude differential diagnosis. The histological manifestations include parenchymatous necrosis, small vessel vasculitis and granulomatous inflammation not vernix (2). The inflammatory infiltrate is usually composed of lymphocytes, neutrophils, plasmocytes, eosinophils, polymorphonuclear giant cells and evidence of leukocytoclastic vasculitis. (10,19)
MRI is the main tool used to identify neurological involvement. Previous articles shows dural involvement at the thoracic level of the spinal cord, as shown in the following Figure 1.
The Figure 2 shows the thickening and dural mass formed compressing the spinal cord and extending from Th2 to Th8, normointense on T1 with limited enhancement after gadolinium administration and hypointense on T2 (20).
The mass and dural thickening characteristic of GW can reach and injure various levels of the spinal cord according to their length and must be differentiated from other diseases such as neurosarcoidosis, cancer, infectious meningitis, tuberculosis and neurosyphilis through clinical manifestations radiological exams and biopsy of the lesion (6,7).
The conventional treatment consists of corticosteroids like prednisone 1 mg / kg / day for 4-6 weeks, gradually withdrawn completed in 6 months. It should be associated cyclophosphamide 2-3 mg / kg / day adjusted according to the number of lymphocytes--which must be kept around 1,000 / [mm.sup.3] and withdrawn after 1 year of remission (13,2,4). The main side effects of this treatment shall include predisposition to infection and nausea, may associate antiemetics, and antibiotics prophylactically.
There are also reports of cases with neurological involvement in patients with refractory Wegener's granulomatosis treated with weekly injections of rituximab 375 mg / [m.sup.2] for 4 weeks and were able to achieve remission of the disease associated with the decline of ANCA titles and depletion of B cells in peripheral blood (9,17,12).
Therefore, in patients with lumbar disease related to GW two directions to the treatment can be taken: conventional treatment when the lumbar disease is part of the initial manifestations of the disease or treatment of refractory shapes which consists most of the cases of neurologic involvement, with rituximab.
Although it is a rare disease, Wegener's granulomatosis has distinct clinical patterns, which may affect various tissues and cause varying degrees of injuries. Its neurological involvement is not uncommon, but its association with low back pain is rare and occurs primarily as a result of spinal cord or nerve root compression arising from vascular injury on dura mater and the subsequent inflammatory process generated. In patients with severe lumbar pain without apparent cause, GW and its neurological involvement should be considered. As diagnostic tools should be associated clinical data, imaging tests, serological marker ANCA and if possible, histopathological analysis of the injury in order to seek higher emplacements for diagnostic confirmation.
Recibido: 27 de agosto de 2016
Aceptado: 25 de septiembre de 2016
(1.) Albayram, Kizilkilie O, Adaletli I. MR Imaging Findings of Spinal Dural Involvement with Wegener Granulomatosis. American Society of Neuroradiology. 2002 Outubro; 23: 1603-1606.
(2.) Antunes T, Barbas CSV. Granulomatose de Wegener. Jornal Brasileiro de Pneumologia. 2005; 31(Supl 1): S21-S6.
(3.) Azuma N, Katada Y, Nishimura N. A case of granuloma in the occipital lobe of a patient. Japan College of Rheumatology. 2008 Abril; 18: 411-415.
(4.) Baaj AA, Vale FL, Carter JD. Granulomatosis with CNS Involvement: A Neuroimaging Clinicopathologic Correlation. American Society of Neuroimaging. 2009 Abril; 19, 2: 194-197.
(5.) Bachmeyer C, Cervera, Marro B. Thoracic spinal cord compression indicating Wegener's granulomatosis in a patient with a previous presumptive diagnosis of microscopic polyangiitis. Joint Bone Spine. 2007; 74: 382-384.
(6.) Bucolo S, Torre V, Montemagno A. Wegener's granulomatosis presenting with otologic and neurologic symptoms: clinical and pathological correlations. J. Oral Pathol Med. ;32: 438-440.
(7.) Ghosh, Banerjee, Saha. Wegener's granulomatosis with dengue fever: an unusual association. International Journal of Rheumatic Diseases. 2012; 15: 47-49.
(8.) Guilfoylea MR, Khanc, Helmya. Spinal intradural haemorrhage in a patient with Wegener's Granulomatosis. Clinical Neurology and Neurosurgery. 2010; 112: 341-343.
(9.) Hughes, Barkhoudarian, Ciarlini P. Refractory pituitary glanulomatosis with polyangiitis (Wegener's) treated with rituximab. Endocrine Practice. 2013 Janeiro--Fevereiro; 19(1).
(10.) Marzano AV, Balice Y, Papini Mea. Localized Wegener's granulomatosis. Journal of the European Academy of Dermatology and Venereology. 2011; 25: 1466-1470.
(11.) Mentzel HJ, Neumann Fitzek. MR Imaging in Wegener Granulomatosis of the Spinal Cord. American Society of Neuroradiology. 2003 Janeiro; 24: 18-21.
(12.) Nagashima, Maguchi S, Terayama. P-ANCA-positive Wegener's granulomatosis presenting with hypertrophic pachymeningitis and multiple cranial neuropathies: Case report and review of literature. Neuropathology. 2000; 1: 23-30.
(13.) Olivencia-Simmons. Wegener's granulomatosis: Symptoms, diagnosis, and treatment. Journal of the American Academy of Nurse Practitioners. 2007.
(14.) Pradhan VD, Badakere SS, Ghosh K. ANCA: Serology in Wegener's granulomatosis. Indian J Med Sci. 2005 Julho; 59(7).
(15.) Provenzale JM, Allen NB. Wegener Granulomatosis: CT and Mr Findings. American Society of Neuroradiology. 1996 Abril; 17: 785-792.
(16.) Rovaris M, Viti B, Ciboddo. Cervical cord magnetic resonance imaging findings in systemic immune-mediated diseases. Journal of the Neurological Sciences. 2000; 176: 128-130.
(17.) Sharma A, Kumar, Wanchu. Successful treatment of hypertrophic pachymeningitis in refractory Wegener's granulomatosis with rituximab. Clinical Rheumatology. 2009 Outubro; 29: 107-110.
(18.) Spisek, Kolouchova, JenSovsky. Combined CNS and pituitary involvement as a primary manifestation of Wegener granulomatosis. Clinical Rheumatology. 2006; 25: 739-742.
(19.) Takaoka, Hashimoto, Nogi. A case of granulomatosis with polyangiitis (Wegener's granulomatosis) manifested with asymptomatic intracerebral hemorrhage. The Japan Society for Clinical Immunology. 2013; 36: 58-61.
(20.) Wang DC, Wei JW, Liu JH. The upper thoracic spinal cord compression as the initial manifestation of Wegener's granulomatosis: a case report. Eur Spine J. 2007 Fevereiro; 16: 296-300.
(21.) Woywodt A, Haubitz, Haller. Wegener's granulomatosis. Lancet. 2006; 367: 1362-1366.
Nicollas Nunes Rabelo
Av. Antonio Diederichsen, n190, Ap 193, Jardim America, cep: 14020250, Ribeirao Preto, SP.
Nicollas Nunes Rabelo , Igor de Sousa Furtado , Daniel Alves Branco Valli, Luciano Jose Silveira Filho , Vitor Hugo Honorato Pereira , George Santos dos Passos , Paulo Eduardo Fernandes Rodovalho , Jander Moreira Monteiro , Renato Pontes Sader , Neiffer Nunes Rabelo , Luiz Antonio Araujo Dias Junior , Koji Tanaka , Fernando Eduardo Plastina , Carlos Umberto Pereira , Luiz Antonio Araujo Dias 
 Neurosurgery Resident, Department of Neurosurgery, Santa Casa Hospital; Ribeirao Preto, Sao Paulo, Brazil.
 Medical Student, Barao de Maua University Center, Ribeirao Preto, Sao Paulo, Brazil.
 Medical Student, Faculdade Atenas, Paracatu, Minas Gerais, Brazil.
 Department of Neurosurgery, Santa Casa Hospital, Ribeirao Preto, Sao Paulo, Brazil.
 Department of Neurosurgery of FBHC and Neurosurgery Service, Aracaju, Sergipe, Brazil.
 Neurosurgeon and Professor, Neurosurgery Department, Santa Casa Hospital; Ribeirao Preto, SP, Brazil. Neurosurgery service of Santa Casa de Misericordia de Ribeirao Preto, Brazil.
Caption: Figure 1. Histology of skin showing epidermal ulceration and dense dermal infiltrate composed of lymphocytes, neutrophils, eosinophils and some scattered giant cells.
Caption: Figure 2. (a) Sagittal view showing extensive thickening of the dural space surrounding and compressing the spinal cord; (b) sagittal image showing hyperintense edema in the thoracic spinal cord extending super and inferiorly.
Table 1. Diagnostic criteria of the American College of Rheumatology published in 1990 Nasal or oral inflammation Nodules, fixed infiltrates or cavitation on chest radiography Microscopic hematuria or more than 5 erythrocytes per high-power field Granulomatous inflammation present in the biopsy Table 1: Presence of at least two of these criteria may mean a diagnosis of Wegener's granulomatosis with 82.2% sensitivity and 92% specificity compared to other vasculitis.
|Printer friendly Cite/link Email Feedback|
|Title Annotation:||Revision Clinica|
|Author:||Nunes Rabelo, Nicollas; de Sousa Furtado, Igor; Branco Valli, Daniel Alves; Silveira Filho, Luciano|
|Publication:||Revista Chilena de Neurocirugia|
|Date:||Jun 1, 2017|
|Previous Article:||Hemispherectomy in Treatment of seizures: current perspectives of the indications, techniques and complications--Literature Review.|
|Next Article:||Estimados Colegas Neurocirujanos de Chile.|